WASATCH ADVISORS LP - 30 Sep 2025 SCHEDULE 13G/A Report for Esperion Therapeutics Inc COM (ESPR)

Filing Manager
WASATCH ADVISORS LP
Reporting Manager
Wasatch Advisors LP
Symbol
ESPR
Shares outstanding
201,767,343 shares
Disclosed Ownership
7,061,857 shares
Ownership
3.5%
Form type
SCHEDULE 13G/A
Filing time
12 Nov 2025, 15:32:33 UTC
Date of event
30 Sep 2025
Previous filing
07 Apr 2025

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Wasatch Advisors LP 3.5% 7,061,857 6,219,311 0 Mike Yeates CEO